Elissa Hudspeth

654 total citations
16 papers, 398 citations indexed

About

Elissa Hudspeth is a scholar working on Public Health, Environmental and Occupational Health, Parasitology and Molecular Biology. According to data from OpenAlex, Elissa Hudspeth has authored 16 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 6 papers in Parasitology and 5 papers in Molecular Biology. Recurrent topics in Elissa Hudspeth's work include Research on Leishmaniasis Studies (7 papers), Parasites and Host Interactions (5 papers) and Trypanosoma species research and implications (5 papers). Elissa Hudspeth is often cited by papers focused on Research on Leishmaniasis Studies (7 papers), Parasites and Host Interactions (5 papers) and Trypanosoma species research and implications (5 papers). Elissa Hudspeth collaborates with scholars based in United States, Switzerland and Mexico. Elissa Hudspeth's co-authors include Christopher A. Seid, Peter J. Hotez, María Elena Bottazzi, Jeroen Pollet, C. Patrick McAtee, Bin Zhan, Wen‐Hsiang Chen, Ulrich Strych, Wanderson Rezende and Oluwatoyin A. Asojo and has published in prestigious journals such as Scientific Reports, Journal of Pharmaceutical Sciences and Vaccine.

In The Last Decade

Elissa Hudspeth

15 papers receiving 392 citations

Peers

Elissa Hudspeth
Wanderson Rezende United States
Leroy Versteeg United States
Lúcio Ayres Caldas Brazil
Darly J. Manayani United States
Cristina Poveda United States
Robert Adamu Shey Cameroon
Biswas Neupane United States
Gabriela Mellado‐Sánchez Mexico
Rajashree Chowdhury Bangladesh
Megan Pavy Australia
Wanderson Rezende United States
Elissa Hudspeth
Citations per year, relative to Elissa Hudspeth Elissa Hudspeth (= 1×) peers Wanderson Rezende

Countries citing papers authored by Elissa Hudspeth

Since Specialization
Citations

This map shows the geographic impact of Elissa Hudspeth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elissa Hudspeth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elissa Hudspeth more than expected).

Fields of papers citing papers by Elissa Hudspeth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elissa Hudspeth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elissa Hudspeth. The network helps show where Elissa Hudspeth may publish in the future.

Co-authorship network of co-authors of Elissa Hudspeth

This figure shows the co-authorship network connecting the top 25 collaborators of Elissa Hudspeth. A scholar is included among the top collaborators of Elissa Hudspeth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elissa Hudspeth. Elissa Hudspeth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hudspeth, Elissa, et al.. (2024). Enhancing AAV process quality and efficiency: three case studies highlighting the benefits of upgraded analytics on downstream process development. Cell and Gene Therapy Insights. 10(9). 1377–1392–1377–1392.
2.
Luo, Zhipu, Rabih Darwiche, Elissa Hudspeth, et al.. (2017). Crystal Structure of MpPR-1i, a SCP/TAPS protein from Moniliophthora perniciosa, the fungus that causes Witches’ Broom Disease of Cacao. Scientific Reports. 7(1). 7818–7818. 10 indexed citations
3.
Biter, Amadeo B., Elissa Hudspeth, Christopher A. Seid, et al.. (2017). Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas Disease. Journal of Pharmaceutical Sciences. 107(5). 1468–1473. 20 indexed citations
4.
Asojo, Oluwatoyin A., Zhuyun Liu, Jeroen Pollet, et al.. (2017). Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis. PLoS neglected tropical diseases. 11(3). e0005374–e0005374. 10 indexed citations
5.
Chen, Wen‐Hsiang, Amadeo B. Biter, Wanderson Rezende, et al.. (2017). Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate. Journal of Pharmaceutical Sciences. 106(8). 1961–1970. 71 indexed citations
6.
Luo, Zhipu, Rabih Darwiche, Elissa Hudspeth, et al.. (2017). Crystal Structure of Borrelia turicatae protein, BTA121, a differentially regulated  gene in the tick-mammalian transmission cycle of relapsing fever spirochetes. Scientific Reports. 7(1). 15310–15310. 2 indexed citations
7.
Barry, Meagan A., et al.. (2017). 3M‐052 as an adjuvant for a PLGA microparticle‐based Leishmania donovani recombinant protein vaccine. Journal of Biomedical Materials Research Part B Applied Biomaterials. 106(4). 1587–1594. 8 indexed citations
8.
Hudspeth, Elissa, Christopher A. Seid, Junfei Wei, et al.. (2016). Expression and purification of an engineered, yeast-expressedLeishmania donovaninucleoside hydrolase with immunogenic properties. Human Vaccines & Immunotherapeutics. 12(7). 1–14. 8 indexed citations
9.
Darwiche, Rabih, et al.. (2016). Structural and functional characterization of the CAP domain of pathogen-related yeast 1 (Pry1) protein. Scientific Reports. 6(1). 28838–28838. 33 indexed citations
10.
McAtee, C. Patrick, Christopher A. Seid, Elissa Hudspeth, et al.. (2016). Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis. Protein Expression and Purification. 130. 129–136. 11 indexed citations
11.
Seid, Christopher A., Kathryn M. Jones, Jeroen Pollet, et al.. (2016). Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease. Human Vaccines & Immunotherapeutics. 13(3). 621–633. 43 indexed citations
12.
Seid, Christopher A., Elena Curti, R. Mark Jones, et al.. (2015). Expression, purification, and characterization of theNecator americanusaspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine. Human Vaccines & Immunotherapeutics. 11(6). 1474–1488. 28 indexed citations
13.
Ramírez-Sierra, María Jesús, Miguel Rosado‐Vallado, Christopher A. Seid, et al.. (2015). Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice. Vaccine. 33(36). 4505–4512. 44 indexed citations
14.
Curti, Elena, Christopher A. Seid, Elissa Hudspeth, et al.. (2014). Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate. Human Vaccines & Immunotherapeutics. 10(7). 1914–1925. 26 indexed citations
15.
Chen, Wen‐Hsiang, Lanying Du, Cuiqing Ma, et al.. (2013). Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate. Human Vaccines & Immunotherapeutics. 10(3). 648–658. 80 indexed citations
16.
Wang, Ping & Elissa Hudspeth. (2011). Increased Body Mass Index but Not Common Vitamin D Receptor, Peroxisome Proliferator–Activated Receptor γ, or Cytokine Polymorphisms Confers Predisposition to Posttransplant Diabetes. Archives of Pathology & Laboratory Medicine. 135(12). 1581–1584. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wanderson Rezende Breakdown of academic impact, for papers by Leroy Versteeg Breakdown of academic impact, for papers by Lúcio Ayres Caldas Breakdown of academic impact, for papers by Darly J. Manayani Breakdown of academic impact, for papers by Cristina Poveda Breakdown of academic impact, for papers by Robert Adamu Shey Breakdown of academic impact, for papers by Biswas Neupane Breakdown of academic impact, for papers by Gabriela Mellado‐Sánchez Breakdown of academic impact, for papers by Rajashree Chowdhury Breakdown of academic impact, for papers by Megan Pavy
Rankless by CCL
2026